NEP-TUNE: Neuropathic Pain - Treatment With Pregabalin Under Real-life Conditions in Denmark

Viatris

Status: Completed

Conditions: Peripheral Neuropathic Pain

Treatments: Other: No intervention. Non-interventional study

Study type: Observational

Funder types: Industry

Identifiers

NCT01524796

A0081292

NEP-TUNE (Other Identifier)

Details and patient eligibility

About

Observational study to assess the effectiveness and use of pregabalin (Lyrica) in the treatment of patients with peripheral neuropathic pain in real-life daily clinical practice.

Full description

General practitioners and specialists participate in the study. When a subject, independently of the study and before consideration for observation in the study has been prescribed pregabalin for treatment of peripheral NeP, the subject can (before first dose of pregabalin is taken) be included in the observational program.

Enrollment: 128 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Subjects aged 18 years or over.

• Subjects diagnosed with peripheral neuropathic pain.

• Subjects that independently of the study and before consideration for observation in the study have been prescribed pregabalin for treatment of peripheral neuropathic pain either.

  1. for the first time ('first prescription patients') or
  2. that have not used pregabalin within the previous 6 months but are prescribed pregabalin again ('re-treatment patients')

• Subjects that haven't taken the first dose of the prescribed pregabalin yet.

Exclusion criteria

• Subjects not consenting to participate.
• Subjects that at study inclusion (baseline) are on treatment with pregabalin for generalized anxiety or epilepsy.

Trial design

128 participants in 1 patient group

Patients with peripheral neuropathic pain treated with Lyrica

Treatment:

Other: No intervention. Non-interventional study